Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reduce Bolus Injection of Bivalirudin
NCT03588611Phase 4Completed
- Start
- Oct 2019
- Primary completion
- Jun 2021
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of bivalirudin in acute coronary syndrome (ACS). Started Oct 2019; status: completed.
02
Drugs
bivalirudin
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT03588611.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03588611.